During the past decade, Albany Med College / Division of HIV Medicine A158 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albany Med College / Division of HIV Medicine A158" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator, "Hoechst Marion Roussel" with 1 trials as a collaborator and "Lederle Laboratories" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Albany Med College / Division of HIV Medicine A158" are "HIV Infections" (6 trials), "Mycobacterium Avium-intracellulare Infection" (1 trials), "Sarcoma, Kaposi" (1 trials) and "Tuberculosis" (1 trials). Many other conditions were trialed in "Albany Med College / Division of HIV Medicine A158" in a lesser frequency.

Most popular intervention types in "Albany Med College / Division of HIV Medicine A158" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (3 trials), "Didanosine" (2 trials), "Nevirapine" (2 trials), "Clarithromycin" (1 trials) and "Delavirdine mesylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Albany Med College / Division of HIV Medicine A158" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Albany Med College / Division of HIV Medicine A158". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Albany Med College / Division of HIV Medicine A158, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Albany Med College / Division of HIV Medicine A158, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".